Alkermes plc (ALKS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
PresentationSo with that out of the way, let me turn it over to Alkermes, CEO, Richard Pops.Because of JPMorgan's involvement with the pending transaction, we're not going to take any Q&A related to the pending deal, and I'm not going to be discussing that.Great. Welcome, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we're continuing the 44th Annual Healthcare Conference today with Alkermes. We're going to hear a presentation from the management team, and then we're going to go into ...